Metabolic mechanisms of naphthalene toxicity in lung

萘肺毒性的代谢机制

基本信息

  • 批准号:
    8814765
  • 负责人:
  • 金额:
    $ 42.77万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-20 至 2018-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Naphthalene (NA) is an acute respiratory toxicant and a potential human lung carcinogen. Human exposure to NA is widespread, but human susceptibility to NA toxicity is poorly understood. The verdict on human susceptibility to NA toxicity will have a significant impact on public health, could save many lives, but involves economic costs. The overall theme of this ViCTER program is to study mechanisms of lung toxicity, including tolerance, induced by NA, in order to improve assessment of human lung cancer risks from NA and other related toxicants. Three Aims are proposed, 1) to define whether NA is a genotoxic carcinogen through a direct mechanism; 2) to test the role of inflammatory cell estrogen production in NA-induced lung toxicity and tolerance; and 3) to identify cellular stress response for NA-induced lung toxicity and tolerance. These Aims significantly expand the scope of the current project by studying molecular and cellular events downstream of the initial bio-activation step, while the parent grant is focused on the NA bio-activation step. The consortium allows extensive collaborations among the participants, in sharing of animal models, unique skills (e.g., airway dissection), instruments, and molecular, cellular, and genotoxic perspectives. Data from the Aims will provide complementary views of the complex, multi-step process of NA-induced tissue damage and repair that lead to preneoplastic changes and eventual carcinogenesis. Aim 1 will provide much needed data on whether NA induces stable DNA adducts in the lung in vivo, and will translate our studies to a more human-like model system. The results would drive risk estimation, guide future mechanistic studies, and provide methodology and approaches for testing other carcinogens. Aim 2 will produce a novel knockout mouse model and establish role of macrophage-derived estrogen in NA-induced hyper proliferative response and tolerance, which precedes development of hyperplastic/dysplastic nodules. Aim 3 will identify the specific reactive oxygen species damage driving acute lung toxicity and signaling pathways that allow for NA-induced tolerance. The results would provide insight for potential mitigating agents and biomarkers for future translational studies to identify and protect at-risk individuals.
 描述(由申请方提供):萘(NA)是一种急性呼吸道毒物,也是一种潜在的人类肺癌致癌物。人类暴露于NA是广泛的,但人类对NA毒性的易感性知之甚少。关于人类对NA毒性敏感性的裁决将对公共卫生产生重大影响,可以挽救许多生命,但涉及经济成本。该ViCTER计划的总体主题是研究NA诱导的肺毒性机制,包括耐受性,以改善NA和其他相关毒物对人类肺癌风险的评估。提出了三个目的:1)通过直接机制确定NA是否是遗传毒性致癌物; 2)测试炎性细胞雌激素产生在NA诱导的肺毒性和耐受性中的作用; 3)鉴定NA诱导的肺毒性和耐受性的细胞应激反应。这些目标通过研究初始生物活化步骤下游的分子和细胞事件,显着扩大了当前项目的范围,而母基金则专注于NA生物活化步骤。该联盟允许参与者之间进行广泛的合作,分享动物模型,独特的技能(例如,气道解剖)、仪器和分子、细胞和遗传毒性观点。来自目标的数据将为NA诱导的组织损伤和修复的复杂多步骤过程提供补充观点,这些过程导致肿瘤前变化和最终致癌。目的1将提供关于NA是否在体内肺中诱导稳定的DNA加合物的急需的数据,并将我们的研究转化为更像人类的模型系统。这些结果将推动风险评估,指导未来的机理研究,并为测试其他致癌物提供方法和途径。目的2将产生一种新的基因敲除小鼠模型,并建立巨噬细胞来源的雌激素在NA诱导的过度增殖反应和耐受中的作用,这先于增生/发育不良结节的发展。目的3将确定特定的活性氧损伤驱动急性肺毒性和信号通路,允许NA诱导的耐受性。这些结果将为未来的转化研究提供潜在的缓解剂和生物标志物,以识别和保护高危人群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Xinxin Ding其他文献

Xinxin Ding的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Xinxin Ding', 18)}}的其他基金

Human CYP2A and respiratory tract xenobiotic toxicity
人类 CYP2A 和呼吸道外源性毒性
  • 批准号:
    8869326
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
Human CYP2A and respiratory tract xenobiotic toxicity
人类 CYP2A 和呼吸道外源性毒性
  • 批准号:
    8874543
  • 财政年份:
    2014
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8840377
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    9765706
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    9921370
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    9352924
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8852124
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    10403995
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic mechanisms of naphthalene toxicity in lung
萘肺毒性的代谢机制
  • 批准号:
    8589793
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:
Metabolic Mechanisms of Naphthalene Toxicity in Lung
萘毒性肺代谢机制
  • 批准号:
    10612426
  • 财政年份:
    2013
  • 资助金额:
    $ 42.77万
  • 项目类别:

相似海外基金

Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
  • 批准号:
    10648387
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
  • 批准号:
    10591804
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
  • 批准号:
    10741574
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
  • 批准号:
    10720687
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
  • 批准号:
    10719249
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
  • 批准号:
    23K07651
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
  • 批准号:
    10679944
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
  • 批准号:
    10701207
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
Identification of novel phenotypes of acute lung injury using multimodal longitudinal data
使用多模态纵向数据识别急性肺损伤的新表型
  • 批准号:
    MR/Y000404/1
  • 财政年份:
    2023
  • 资助金额:
    $ 42.77万
  • 项目类别:
    Fellowship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了